Kevin Sullivan

CEO at 3DBioFibR

Speaker

Kevin Sullivan is CEO of 3DBioFibR, a Canadian biomaterials company producing high performance biopolymer fibers for applications across life sciences, medical devices, and advanced materials. A biotechnology executive and Canadian Navy Veteran with more than 20 years of industry experience, Kevin has built and financed multiple early-stage biotechnology companies, raised more than $90 million in funding, and experienced in technology licensing with pharmaceutical, academic, and government partners. Kevin has also previously led a biotechnology company through an IPO on the TSX Venture Exchange.

At 3DBioFibR, Kevin leads corporate strategy, financing, and commercialization as the company expands its proprietary Contact Drawing platform and develops strategic partnerships with global organizations seeking scalable, high-performance biomaterials. Under his leadership, 3DBioFibR has built meaningful market traction, including 3 signed partnerships, 14 paid development deals, and more than 20 ongoing collaborative projects with organizations evaluating the company’s biomaterials across multiple applications.